Skip to main navigation
Top
Skip to main content
Agios Logo Agios Logo
  • About Us

    About Us

    • Values
    • History
    • Leadership
    • Corporate Social Responsibility
    • Access to Medicines
    • News
      About Us
    • Values

    • History

    • Leadership

    • Corporate Social Responsibility

    • Access to Medicines

    • News

  • Rare Diseases

    Rare Defined Diseases

    • Pyruvate Kinase Deficiency
    • Thalassemia
    • Sickle Cell Disease
    • Our Science
      Rare Diseases
    • Pyruvate Kinase Deficiency

    • Thalassemia

    • Sickle Cell Disease

    • Our Science

  • Pipeline

    Pipeline

  • Our Medicines

    Our Medicines

  • Patients & Partners

    Patients & Partners

    • Patients & Caregivers
      • Clinical Trials

      • Patient Resources

    • Healthcare Providers

      • Healthcare Provider Resources

      • Clinical Data Sharing

    • Partner Opportunities

        Patients & Partners
      • Patients & Caregivers

        • Clinical Trials

        • Patient Resources

      • Healthcare Providers

        • Clinical Data Sharing

      • Partner Opportunities

      • Investors

        Investors

        • News & Events
        • Stock Information
        • Corporate Governance
        • Financials
        • IR Resources

          Investors

        • News & Events

        • Stock Information

        • Corporate Governance

        • Financials

        • IR Resources

      • Inside Agios

        Inside Agios

        • Careers

        • Culture

        • Diversity

        • Commitment to Community

        • Benefits

          Inside Agios
        • Careers

        • Culture

        • Diversity

        • Commitment to Community

        • Benefits

      SEC Filing Details

      • Investors Overview
      • News & Events
        • Press Releases
        • Publications
        • Events & Presentations
      • Stock Information
      • Corporate Governance
        • Leadership
        • Board of Directors
        • Environment, Social and Governance (ESG) Report
      • Financials
        • SEC Filings
        • Annual Reports & Proxy
        • Quarterly Results
      • IR Resources
        • Investor FAQs
        • IR Contact
        • Information Request
        • Email Alerts

      SEC Filing Details

      Document Details

      Form
      10-K
      Filing Date
      Feb 19, 2020
      Document Date
      Dec 31, 2019
      Form Description
      Annual report which provides a comprehensive overview of the company for the past year
      Filing Group
      Annual Filings
      Company
      Agios Pharmaceuticals, Inc.
      Issuer
      AGIOS PHARMACEUTICALS, INC.

      Filing Formats

      View HTML
      Download PDF
      Download DOC
      Download XLS

      XBRL

      XBRL Viewer
      EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
      EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
      EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
      EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
      EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
      XML - XBRL INSTANCE DOCUMENT
      • latest-earnings-call Latest Earnings Call View Replay
      • latest-form-10-k Latest Form 10-K View PDF
      • email-alerts Email Alerts Sign Up
      • corporate-responsibility Corporate Responsibility View PDF

      Connect with us on LinkedIn or follow us on X.

      LinkedIn logo Connect on LinkedIn
      Twitter logoFollow us on X
      • Contact
      • About Us
      • Partner Opportunities
      • Careers
      Agios Logo

      Agios Pharmaceuticals, Inc. © 2026

      All right reserved.

      • Cookies Preferences
      • Copyright Info
      • Compliance
      • Sitemap
      • Privacy Notice
      • Terms of Use